Search alternatives:
teer decrease » greater decrease (Expand Search)
mean decrease » a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
Showing 201 - 220 results of 28,883 for search '(( 50 ((we decrease) OR (teer decrease)) ) OR ( 5 ((nn decrease) OR (mean decrease)) ))', query time: 0.85s Refine Results
  1. 201
    Baseline patient characteristics across neutralizing monoclonal antibody trials.

    Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 202
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 203
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 204
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 205
    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies.

    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 206
    Study Flow Diagram.

    Study Flow Diagram. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 207
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 208
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 209
    Overview of the six original ACTIV-3/TICO trials.

    Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 210
    Type and duration of leisure-time activities performed 5 years after RYGB.

    Type and duration of leisure-time activities performed 5 years after RYGB. by Alice Bellicha (3583493)

    Published 2022
    Save to List
    Saved in:
  11. 211
    Blocking C5L2 decreased C5a-primed neutrophils for ANCA-induced respiratory burst.

    Blocking C5L2 decreased C5a-primed neutrophils for ANCA-induced respiratory burst. by Jian Hao (160736)

    Published 2013
    Save to List
    Saved in:
  12. 212
    AA-deficient <i>sfx</i> mice had decreased articular cartilage.

    AA-deficient <i>sfx</i> mice had decreased articular cartilage. by Richard C. Lindsey (7148168)

    Published 2019
    Save to List
    Saved in:
  13. 213
    Means and Cronbach’s alphas for 5C and VAX-measured vaccination attitudes over 12 months.

    Means and Cronbach’s alphas for 5C and VAX-measured vaccination attitudes over 12 months. by Allyson J. Gallant (9382396)

    Published 2021
    Save to List
    Saved in:
  14. 214
    E<sub>50</sub> values of angle.

    E<sub>50</sub> values of angle. by Junxia Zhou (14381598)

    Published 2024
    Save to List
    Saved in:
  15. 215
    Curve fitting of E<sub>50</sub>.

    Curve fitting of E<sub>50</sub>. by Junxia Zhou (14381598)

    Published 2024
    Save to List
    Saved in:
  16. 216
    Fitting curves of E<sub>50</sub>.

    Fitting curves of E<sub>50</sub>. by Junxia Zhou (14381598)

    Published 2024
    Save to List
    Saved in:
  17. 217
    E<sub>50</sub> values of size.

    E<sub>50</sub> values of size. by Junxia Zhou (14381598)

    Published 2024
    Save to List
    Saved in:
  18. 218
    E<sub>50</sub> fluctuation coefficient.

    E<sub>50</sub> fluctuation coefficient. by Junxia Zhou (14381598)

    Published 2024
    Save to List
    Saved in:
  19. 219
    Fitting relationship of E<sub>50</sub>.

    Fitting relationship of E<sub>50</sub>. by Junxia Zhou (14381598)

    Published 2024
    Save to List
    Saved in:
  20. 220
    Fitting curve of E<sub>50</sub>.

    Fitting curve of E<sub>50</sub>. by Junxia Zhou (14381598)

    Published 2024
    Save to List
    Saved in:

Search Tools: